0113126-SD: Bard OptiFix Absorbable Fixation System, 30 Fasteners

Sign in to add this product to your favorites!
| Price: | $299.99 per box of 1 |
|---|---|
| In Stock: | 0 box of 1 |
| Express: | Need it tomorrow? Order in next 4 hours 49 minutes and choose overnight shipping at checkout. |
We currently do not have this item in stock, but we can email you as soon as it is available.
Additional Details
BD Bard OptiFix Absorbable Fixation System
The OptiFix™ Absorbable Fixation System has been engineered inside and out to provide surgeon confidence and secure fixation in a reliable, easy to use, and ergonomic design.
The OptiFix™ Absorbable Fastener is made from PDLLA and is designed for optimal performance. Fastener features include:
Smooth Fastener Head
- Minimizes the potential for tissue attachment
- Ensures mesh is securely fixated
Hollow Core Design
- Allows tissue ingrowth through the fastener
Angled Tip
- Easily penetrates mesh and tissue
Stabilizers
- Enhances tissue holding strength
- Prevents the fastener from backing out
AccessGUDID Info
- FDA Product Code: GDW
- FDA Product Code Name: STAPLE, IMPLANTABLE
- GMDN Term Code: 45027
- GMDN Term Name: Soft-tissue/mesh anchor, bioabsorbable
- GMDN Term Description: A bioabsorbable device designed to be implanted into ligaments or other soft tissues for soft-tissue approximation and/or to serve as a site of attachment for surgical mesh or sutures; it is not intended to anchor soft tissues to bone, nor repair cartilage, and is not intended for ophthalmic use. It is available in a variety of designs (e.g., screw-, punch-, staple-like) and is made of a polymer that can be chemically degraded via natural body processes. It is intended to create a fixed anchor point and is not a suture-based fastening device such as a T-fastener. It is typically implanted with the use of a specialized applicator which may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE